GLP-1 therapies have been established using two main approaches: DPP4-resistant GLP-1 agonists/GLP-1RA and DPP-4 inhibitors, both of which aim to prolong the life-time of circulating GLP-1(736) amide
This is a judgment call that depends on specific circumstances and how questions are phrased
Xu SFS, Andersen DB, Izarzugaza JMG, Kuhre RE, Holst JJ (2020) In the rat pancreas, somatostatin tonically inhibits glucagon secretion and is required for glucose-induced inhibition of glucagon secretion
The medication is administered through a convenient once-weekly subcutaneous injection, improving adherence and making it easier for our patients to incorporate into their routines
Oral supplements typically take a few weeks of consistent, daily use to produce noticeable, gradual effects